Intravenous Lipid Emulsion Increased Muscles Power and Survival Time of Phenobarbital in Intoxicated Rats

Document Type: Original article

Authors

1 Medical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

3 Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Background: Phenobarbital (PHB) is an anticonvulsant drug that poisoning with it leads to stupor or coma and in higher doses may induce severe respiratory depression and cardiovascular collapse. Intravenous Lipid Emulsion (ILE) has been used to treat drug toxicity and for parenteral nutrition.
Methods: Ten male rats that had been intoxicated by 100 mg/kg of PHB were treated intravenously by 18.6 ml/kg of ILE20 or similar dose of normal saline. Subject rats were checked before PHB injection (zero time), 0.5 hr before ILE20% (or normal saline infusion) and 1, 3, and 6 hr after PHB toxic injections. On each check point, we tested the blood pressure, muscular power score and mortality rate.
Results: There were no significant differences between blood pressures of two groups at all. ILE was able to increase rats’ muscular power scores at the 3rd and 6th hours check points (p=0.007 and 0.0371, respectively). ILE also increased the survival period of intoxicated rats; however it did not change the mortality rate.
Conclusion: ILE was able to reverse the muscles power reduction and could improve the survival period among intoxicated rats.

Keywords


Introduction
Phenobarbital (PHB) is an anticonvulsant, which causes acute poisoning due to easy availability 1,2. Suicidal actions are the major cause of phenobarbital intoxication 1. PHB poisoning leads to stupor or coma and in high dose induces severe respiratory depression and cardiovascular collapse. These may result fatal outcome up to 7% of intoxicated patients 1. Authors of literatures suggest no especial antidote; however, they recommended some methods such as alkaline diuresis, activated charcoal and hemodialysis.
Administration of Intravenous Lipid Emulsion (ILE) to severe intoxicated patients could reverse poisoning and rescue their lives 3. Sirianni and his colleagues reported the use of ILE following 70 min of unsuccessful standard cardiopulmonary resuscitation in a 17-year-old girl who developed seizures and cardiovascular collapse after intentionally ingesting an overdose of bupropion, lamotrigine and amphetamine. Her cardiovascular status has been improved and she recovered with near-normal neurologic function 4.
In past ten years, there are several animal studies that reveled antidotal effect of ILE against drug intoxication 3,5-9. Moshiri et al reported that ILE could reversed the hypotension, hypothermia, catalepsy and miosis of haloperidol intoxicated rabbits sooner than normal saline 5,6. His colleagues evaluated the ILE effect on tramadol induced seizure and hypotension in rabbit and found similar effects 7. We evaluated the effect of ILE on PHB poisoning in this issue.

Materials and Methods
Ten male rats weighting 200-250 g were housed in cages with a 12 hr light/dark cycle and easy access to food and water. Animals were divided into two groups consisting of five rats.
Ampoules of PHB (200 mg/ml, Chemidarou, Iran) were diluted and administrated to all animals. They also received ILE 20% [Intralipid Emulsion (Fresenius Kabi AB) Spain].
We applied 18.6 ml/kg ILE 20% or 18.6 ml/kg Normal Saline (NS), as a control, 30 min after 100 mg/kg PHB injection. ILE or NS were infused over 15 min. Rats received the injections through the vein cannula.
The animals were monitored before PHB injection (zero time), 0.5 hr (before ILE 20% or NS infusion) and 1, 3, and 6 hr after PHB injection. The muscular powers of animals were evaluated by scoring scale as Grade 4: normal mobility; Grade 3: ataxic gait; Grade 2: stretch movements after tail stimulation; Grade 1: standing after tail stimulation; Grade 0: no voluntary movements after tail stimulation, four limb paralysis 9. All animals were evaluated by an individual unaware of the groups. Blood pressures of all animals were measured using tail-cuff method (Power lab, Data Acquisition Systems, US). Mortality rates and survival times were also recorded.
The data were expressed as the mean ± SEM. Unpaired T test was used to determine the significance of a difference in blood pressure and survival times between groups. Non parametric tests were used if necessary. Fisher’s exact test was used to evaluate differences in mortality rate of different groups. The alpha level was set at 0.05. All statistical analyses were performed in SPSS 11.5.

Results
Half an hour after PHB toxic dose administration, the blood pressure of animals could not be detectable and animals were hypotensive. We found no significant difference between blood pressure of NS and ILE treated groups at all evaluating times, and there was no difference in returning to normal blood pressure between two groups (Figure 1).
There was no significant difference in animal muscular power scores before PHB administration. The scores significantly increased 3 and 6 hr after ILE infusion compare with control group (p= 0.007 and 0.0371, respectively), (Figure 2).
There was no statistically significant difference between mortality rates of ILE treated and control groups (0% and 60% respectively; p=0.167), (Table 1). However, the mean survival time of ILE group was higher than NS group (Table 1).

Discussion
PHB is a relative lipid-insoluble barbiturate that at high doses induces cardiovascular depression with hypotension, nystagmus, ataxia, severe respiratory depression, coma and death 10. Blocking the sympathetic ganglion and inhibition of medullar vasomotor centers by PHB at high doses induce vasodilatation, hypotension, bradycardia and low cardiac output 11. ILE could reverse hypotension induced by lipophilic-drug overdose such as haloperidol, methamphetamine and propranolol 6,8,12. However, it is not able to reveres non lipophylic drug induced hypotension, such as atenolol 13. In our study, the administration of ILE could not reverse PHB induced hypotension sooner than normal saline, as volume expander.
The most important hypothesized mechanism of ILE therapy in lipophilic drug induced toxicity is lipid sink. Based on this theory, ILE relieves the toxicity of lipophilic xenobiotics via redistribution from action site and receptors in tissue to plasma or inert lipid induced compartment 14-21. It has been shown that the lipid solubility of drug has a direct relationship with ILE detoxification capacity 16,17. PHB is relatively lipid-insoluble barbiturate with volume of distribution of 0.5-1 mg/L 22. It seems that the ILE effect on survival and muscles power of PHB intoxicated rats are not explained by lipid sink theory and some other mechanisms might be involved 5,7,18-21.
PHB induces Central Nervous System (CNS) depression by enhancing GABAergic transmission 22. There are some evidence on cross talking of N-methyl-D-aspartate (NMDA) and GABAA receptors on neurons, two important excitatory and inhibitory receptors 23. NMDA receptor activation cross-inhibits GABAA receptor in a concentration dependent manner 24. Cong et al reported that the inhibitory effect of NMDA receptor activation on GABAA receptor mediated by calcium influx through NMDA receptors 24. Stelzer and coworkers evaluated the effect of intralipid on cell membrane of mice cultured cortical neurons, by patch clamp technique. They revealed that intralipid activates NMDA receptor channels in a concentration-dependent manner in cortical neurons 23. So it seems that part of effect of ILE on PHB toxicity is related to reversing GABAA receptor inhibition through cross talking of NMDA activation by lipid. However, it has been stated by Weigt et al that ILE has a dual effect on NMDA receptor channels. According to their research projects ILE can decrease 25,26 and increase 27 NMDA receptor activity.
PHB is excreted unchanged through kidney and due to its low pKa (7.24), urine alkalinization to pH of 7.5-8.0 can increase PHB excretion up to 5-10 folds 11,22,28. Intralipid has alkaline pH (pH=8) 29. The blood volume of a male rat is 68.6 ml/kg 30 and we administrated ILE in 27% of total rat blood volume (18.6/68.6). It is suspected that ILE by raising the blood pH can increase the PHB renal excretion. However, we have not recorded rat’s blood pH or urine pH. On the other hand, our control group received normal saline without bicarbonate, and we could not able to evaluate this hypothesis. Fox et al evaluated pH of premature infants after continues administration of 5 ml/kg (1 g/kg) intralipid and they found no difference on pH of their patients at 4 hours later 31. We used much higher dose and infusion rate.
Nutritional theory may be another suggested mechanism to explain rising muscles activity score of ILE group. However, this theory is expressed for cardiac muscles 3, there are some evidences that ILE has similar effects on skeletal muscles. Free fatty acid oxidation is an energy source of skeletal muscles cells. This process is limited by two steps, the availability of free fatty acid and the abundance of fatty acid transports into mitochondria 32-34. The infusion of high dose ILE raises the serum level of free fatty acid secondary to activation of lipoprotein lipase 35, so it seems that improving rat muscles power after ILE infusion is partly due to free fatty acid availability to skeletal muscles.

Conclusion
In conclusion, ILE could reverse the reduction of muscles power and improve survival time of PHB intoxicated rats. However, further detailed research needed to confirm this finding and to reveal the exact mechanisms.

Acknowledgments
The authors wish to thank the Vice Chancellor of Research, Mashhad University of Medical Sciences for their financial support.

Conflict of Interest
The authors report no declarations of interest.

1. Kiran S, Chhabra B. Management of barbiturate poisoning- a case report. Indian J Anaesth. 2002;46(6):480-482.
2. Spiller HA, Bosse GM. Management of acute anticonvulsant overdose. CNS Drugs. 1996;6(2):113-129.
3. Moshiri M, Etemad L. Effect of intravenous lipid emulsions in acute toxicity: mini-review. IJBMS. 2011;14:75.
4. Sirianni AJ, Osterhoudt KC, Calello DP, Muller AA, Waterhouse MR, Goodkin MB, et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med. 2008;51(4):412-415,e1.
5. Moshiri M, Mohammadpour AH, Vahabzadeh M, Etemad L, Memar B, Hosseinzadeh H. Evaluating the effects and safety of intravenous lipid emulsion on haloperidol-induced neurotoxicity in rabbit. Biomed Res Int. 2014;2014:949262.
6. Moshiri M, Vahabzadeh M, Mohammadpour AH, Hosseinzadeh H. Evaluation of intravenous lipid emulsion on haloperidol-induced hypotension in rabbits. Toxicol Ind Health. 2014;32(5):945-952.
7. Vahabzadeh M, Moshiri M, Mohammadpour AH, Hosseinzadeh H. Promising effects of intravenous lipid emulsion as an antidote in acute tramadol poisoning. Reg Anesth Pain Med. 2013;38(5):425-430.
8. Ghadiri A, Etemad L, Moshiri M, Moallem SA, Jafarian AH, Hadizadeh F, et al. Exploring the effect of intravenous lipid emulsion in acute methamphetamine toxicity. Iran J Basic Med Sci. 2017;20(2):138-144.
9. Moshiri M, Vahabzadeh M, Etemad L, Hosseinzadeh H. Failure of intravenous lipid emulsion to reduce diazinon-induced acute toxicity: a pilot study in rats. Iran J Pharm Res. 2013;12(4):897-902.
10. Sweetman SC, Blake OS, Brayfield A, McGlashan JM, Neathercoat GC, Parsons AV. Martindale, The complete drug reference. 36th ed. London: Pharmaceutical Press; 2009.
11. Frank AB. Clinical toxicology principles and mechanisms. London: CRC PRESS; 2005.
12. Harvey MG, Cave GR. Intralipid infusion ameliorates propranolol-induced hypotension in rabbits. J Med Toxicol. 2008;4(2):71-76.
13. Cave G, Harvey M. Lipid emulsion may augment early blood pressure recovery in a rabbit model of atenolol toxicity. J Med Toxicol. 2009;5(1):50-51.
14. Rothschild L, Bern S, Oswald S, Weinberg G. Intravenous lipid emulsion in clinical toxicology. Scand J Trauma Resusc Emerg Med. 2010;18:51.
15. Manavi MV. Lipid infusion as a treatment for local anesthetic toxicity: a literature review. AANA J. 2010;78(1):69-78.
16. French D, Smollin C, Ruan W, Wong A, Drasner K, Wu AH. Partition constant and volume of distribution as predictors of clinical efficacy of lipid rescue for toxicological emergencies. Clin Toxicol (Phila). 2011;49(9):801-809.
17. Weinberg G, Lin B, Zheng S, Di Gregorio G, Hiller D, Ripper R, et al. Partitioning effect in lipid resuscitation: further evidence for the lipid sink. Crit Care Med. 2010;38(11):2268-2269.
18. Hoegberg LCG, Gosselin S. Lipid resuscitation in acute poisoning: after a decade of publications, what have we really learned? Curr Opin Anaesthesiol. 2017;30(4):474-479.
19. Levine M, Hoffman RS, Lavergne V, Stork CM, Graudins A, Chuang R, et al. Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity. Clin Toxicol (Phila). 2016; 54(3):194-221.
20. Hoegberg LC, Bania TC, Lavergne V, Bailey B, Turgeon AF, Thomas SH, et al. Systematic review of the effect of intravenous lipid emulsion therapy for local anesthetic toxicity. ClinToxicol (Phila). 2016;54(3):167-93.
21. Hayes BD, Gosselin S, Calello DP, Nacca N, Rollins CJ, Abourbih D, et al. Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration. ClinToxicol (Phila). 2016;54(5):365-404.
22. Lee DC, Ferguson KL. Chapter 74- Sedative-hypnotics. In: Nelson L, Lewin N, Howland MA, Hoffman W, Goldfrank LR, Flomenbaum NE, editors. Goldfrank’s Toxicologic Emergencies. New York: McGroHill; 2011. p. 1060-72.
23. Stelzer A, Slater NT, ten Bruggencate G. Activation of NMDA receptors blocks GABAergic inhibition in an in vitro model of epilepsy. Nature. 1987;326(61140:698-701.
24. Cong D, Tang Z, Li L, Huang Y, Wang J, Chen L. Cross-talk between NMDA and GABA(A) receptors in cultured neurons of the rat inferior colliculus. Sci China Life Sci. 2011;54(6):560-566.
25. Weigt HU, Georgieff M, Fohr KJ, Adolph O. In vitro-evaluation of lipid emulsions as vehicles for the administration of xenon: interaction with NMDA receptors. Acta Neurobiol Exp (Wars). 2009;69(2):207-216.
26. Weigt H, Georgieff M, Beyer C, Georgieff EM, Kuhse J, Fohr KJ. Lipid emulsions reduce NMDA-evoked currents. Neuropharmacology. 2004;47(3):373-380.
27. Weigt HU, Georgieff M, Beyer C, Fohr KJ. Activation of neuronal N-methyl-D-aspartate receptor channels by lipid emulsions. Anesth Analg. 2002;94(2):331-337.
28. Treston AM, Hooper WD. Urinary metabolites of phenobarbitone, primidone, and their N-methyl and N-ethyl derivatives in humans. Xenobiotica. 1992;22(4):385-394.
29. Driscoll DF. Lipid injectable emulsions: 2006. Nutr Clin Pract. 2006;21(4):381-386.
30. Probst RJ, Lim JM, Bird DN, Pole GL, Sato AK, Claybaugh JR. Gender differences in the blood volume of conscious Sprague-Dawley rats. J Am Assoc Lab Anim Sci. 2006;45(2):49-52.
31. Fox WW, Pereira PG, Schwartz JG. Effects of intralipid infusions of arterial blood gases and pulmonary function in small premature neonates. Pediatr Res. 1978;12:524.
32. Jeppesen J, Kiens B. Regulation and limitations to fatty acid oxidation during exercise. J Physiol. 2012;590(5):1059-1068.
33. Jeukendrup AE, Saris WH, Wagenmakers AJ. Fat metabolism during exercise: a review. Part I: fatty acid mobilization and muscle metabolism. Int J Sports Med. 1998;19:231-244.
34. Rasmussen BB, Wolfe RR. Regulation of fatty acid oxidation in skeletal muscle. Annu Rev Nutr. 1999;19:463-84.
35. Peterson J, Bihain BE, Bengtsson-Olivecrona G, Deckelbaum RJ, Carpentier YA, Olivecrona T. Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc Natl Acad Sci USA. 1990;87(3):909-913.